博士論文

Alvocidib inhibits IRF4 expression via super-enhancer suppression and adult T-cell leukemia/lymphoma cell growth

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Alvocidib inhibits IRF4 expression via super-enhancer suppression and adult T-cell leukemia/lymphoma cell growth

Persistent ID (NDL)
info:ndljp/pid/12693483
Material type
博士論文
Author
坂本, 光
Publisher
John Wiley & Sons Australia, Ltd
Publication date
2022-12-07
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
Nagasaki University (長崎大学),博士(医学)
View All

Notes on use at the National Diet Library

Notes on use

Note (General):

Adult T-cell leukemia/lymphoma (ATL) is an intractable hematological malignancy with extremely poor prognosis. Recent studies have revealed that super...

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
坂本, 光
Author Heading
Publication, Distribution, etc.
Publication Date
2022-12-07
Publication Date (W3CDTF)
2022-12-07
Alternative Title
アルボシジブはスーパーエンハンサーを介してIRF4発現を抑制し、成人T細胞白血病・リンパ腫の細胞増殖を抑制する
Degree grantor/type
Nagasaki University (長崎大学)
Date Granted
2022-12-07